Roux-en-Y gastric bypass: Effects on feeding behavior and underlying mechanisms

Journal of Clinical Investigation

Volumn 125, Issue 3, 2015, Pages 939-948

  Manning, Sean ^a,b   Pucci, Andrea ^a,c   Batterham, Rachel L ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APPETITE; BARIATRIC SURGERY; FEEDING BEHAVIOR; FOOD PREFERENCE; HUMAN; METHODOLOGY; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; REVIEW; ROUX EN Y GASTRIC BYPASS; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TASTE; WEIGHT REDUCTION; ANIMAL; FOOD INTAKE; METABOLISM; OBESITY; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY;

MELANOCORTIN 4 RECEPTOR;

ANASTOMOSIS, ROUX-EN-Y; ANIMALS; APPETITE REGULATION; FEEDING BEHAVIOR; GASTRIC BYPASS; HUMANS; OBESITY; OBSERVATIONAL STUDIES AS TOPIC; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 84924047959     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI76305     Document Type: Review

References (128)

1. Swinburn BA, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804-814.
2. Silventoinen K, Rokholm B, Kaprio J, Sørensen TI. The genetic and environmental influences on childhood obesity: a systematic review of twin and adop tion studies. Int J Obes (Lond). 2010;34(1):29-40.
3. Rokholm B, Silventoinen K, Tynelius P, Gamborg M, Sørensen TI, Rasmussen F. Increasing genetic variance of body mass index during th e Swedish obesity epidemic. PLoS One. 2011;6(11):e27135.
4. Ramachandrappa S, Farooqi IS. Genetic approaches to understanding human obesity. J Clin Invest. 2011;121(6):2080-2086.
5. Morton GJ, Meek TH, Schwartz MW. Neurobiology of food intake in health and disease. Nat Rev Neurosci. 2014;15(6):367-378.
6. Gautron L, Elmquist JK. Sixteen years and counting: an update on leptin in energy balance. J Clin Invest. 2011;121(6): 2087-2093.
7. Yang J, et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet. 2011;43(6):519-525.
8. Berndt SI, et al. Genome-wide meta-Analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet. 2013;45(5):501-512.
9. Llewellyn CH, Trzaskowski M, Plomin R, Wardle J. Finding the missing heritability in pediatric obesity: the contribution of genomewide complex trait analysis. Int J Obes (Lond). 2013;37(11):1506-1509.
10. Day FR, Loos RJ. Developments in obesity genetics in the era of genome-wide association studies. J Nutrigenet Nutrigenomics. 2011;4(4):222-238.
11. Mägi R, et al. Contribution of 32 GWAS-identified common variants to severe obesity in European adults referred for bariatric surgery. PLoS One. 2013;8(8):e70735.
12. Qi Q, et al. Fried food consum ption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ. 2014;348:g1610.
13. Loos RJ, Yeo GS. The bigger picture of FTO-the first GWAS-identified obesity gene. Nat Rev Endocrinol. 2014;10(1):51-61.
14. Speakman JR, Rance KA, Johnstone AM. Polymor phisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity (Silver Spring). 2008;16(8):1961-1965.
15. van der Klaauw AA, et al. Obesity-Associated mel anocortin-4 receptor mutations are associated with changes in the brain response to food cues. J Clin Endocrinol Metab. 2014;99(10):E2101-E2106.
16. Karra E, et al. A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest. 2013;123(8):3539-3551.
17. Carnell S, Gibson C, Benson L, Ochner CN, Geliebter A. Neuroimaging and obesity: current knowledge and future directions. Obes Rev. 2012;13(1):43-56.
18. Brooks SJ, Cedernaes J, Schioth HB. Increased prefrontal and parahippocampal activation with reduced dorsolateral prefrontal and insular cortex activation to food images in obesity: a meta-Analysis of fMRI studies. PLoS One. 2013;8(4):e60393.
19. Burger KS,Stice E Variability in reward responsivity and obesity: evidence from brain imaging studies Curr Drug Abuse Rev. 2011 4, 3, 182-189.
20. Lips MA, et al. Resting-state functional connectivity of brain regions involved in cognitive control, motivation, and reward is enhanced in obese females. Am J C lin Nutr. 2014;100(2):524-531.
21. Ziauddeen H, Farooqi IS, Fletcher PC. Obesity and the brain: how convincing is the addiction model? Nat Rev Neurosci. 2012;13(4):279-286.
22. Haltia LT, et al. Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse. 2007;61(9):748-756.
23. Wang GJ, et al. Brain dopamine and obesity. Lancet. 2001;357(9253):354-357.
24. Guo J, Simmons WK, Herscovitch P, Martin A, Hall KD. Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior. Mol Psychiatry. 2014;19(10):1078-1084.
25. Manning S, Pucci A, Finer N. Pharmacotherapy for obesity: novel agents and paradigms. Ther Adv Chronic Dis. 2014;5(3):135-148.
26. El-Sayed Moustafa JS, Froguel P. From obesity genetics to the future of personalized obesity therapy. Nat Rev Endocrinol. 2013;9(7):402-413.
27. Gloy VL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-Analysis of randomised controlled trials. BMJ. 2013;347:f5934.
28. Tam CS, et al. Could the mechanisms of bariatric surgery hold the key for novel therapies? Report from a Pennington Scientific Symposium. Obes Rev. 2011;12(11):984-994.
29. Shin AC, Berthoud HR. Obesity surgery: happy with less or eternally hungry? Trends Endocrinol Metab. 2013;24(2):101-108.
30. Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial-A prospective controlled interv ention study of bariatric surgery. J Intern Med. 2013;273(3):219-234.
31. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427-436.
32. Courcoulas AP, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416-2425.
33. Sumithran P, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597-1604.
34. Larder R, O'Rahilly S. Shedding pounds after going under the knife: guts over glory-why diets fail. Nat Med. 2012;18(5):666-667.
35. Korner J, et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond). 2009;33(7):786-795.
36. Valderas JP, et al. Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss. J Clin Endoc rinol Metab. 2010;95(3):1069-1075.
37. Bray GA, Dahms WT, Atkinson RL, Mena I, Schwartz A. Factors controlling food intake: a comparison of dieting and intestinal bypass. Am J Clin Nutr. 1980;33(2 suppl):376-382.
38. Mathes CM, Spector AC. Food selection and taste changes in humans after Roux-en-Y gastric bypass surgery: a direct-measures approach. Physiol Behav. 2012;107(4):476-483.
39. Schultes B, Ernst B, Wilms B, Thurnheer M, Hallschmid M. Hedonic hunger is increased in severely obese patients and is reduced after gastric bypass surgery. Am J Clin Nutr. 2010;92(2):277-283.
40. Ullrich J, Ernst B, Wilms B, Thurnheer M, Schultes B. Roux-en Y gastric bypass surgery reduces hedonic hunger and improves dietary habits in severely obese subjects. Obes Surg. 2013;23(1):50-55.
41. Laurenius A, et al. Changes in eating behaviour and meal pattern following Roux-en-Y gastric bypass. Int J Obes (Lond). 2012;36(3):348-355.
42. Kofman MD, Lent MR, Swencionis C. Maladaptive eating patterns, quality of life, and weight outcomes following gastric bypass: results of an Internet survey. Obesity (Silver Spring). 2010;18(10):193 8-1943.
43. Pepino MY, Bradley D, Eagon JC, Sullivan S, Abumrad NA, Klein S. Changes in taste perception and eating behavior after bariatric surgery-induced weight loss in women. Obesity (Silver Spr ing). 2014;22(5):E13-E20.
44. Miras AD, et al. Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am J Clin Nutr. 2012;96(3):467-473.
45. Bueter M, et al. Alterations of sucrose preference after Roux-en-Y gastric bypass. Physiol Behav. 2011;104(5):709-721.
46. Bryant EJ, et al. Relationships among tonic and episodic aspects of motivation to eat, gut peptides, and weight before and after bariatric surgery. Surg Obes Relat Dis. 2013;9(5):802-808.
47. Novais PF, Junior IR, Shiraga EC, de Oliveira MR. Food aversions in women during the 2 years after Rouxen-Y gastric bypass. Obes Surg. 2011;21(12):1921-1927.
48. Olbers T, et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg. 2006;244(5):715-722.
49. Flancbaum L, Choban PS, Bradley LR, Burge JC. Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity. Surgery. 1997;122(5):943-949.
50. Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol. 2014;2(2):152-164.
51. Dirksen C, et al. Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass. Neurogastroenterol Motil. 2013;25(4):346.
52. Odstrcil EA, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92(4):704-713.
53. Mumphrey MB, Patterson LM, Zheng H, Berthoud HR. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats. Neurogastroenterol Motil. 2013;25(1):e70-e79.
54. Pournaras DJ, et al. The role of bil e after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology. 2012;153(8):3613-3619.
55. Ahmad NN, Pfalzer A, Kaplan LM. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes (Lond). 2013;37(12):1553-1559.
56. Holst JJ. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. Curr Opin Pharmacol. 2013;13(6):983-988.
57. Korner J, et al. Effects of Roux-en-Y gastri c bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005;90(1):359-365.
58. Chan JL, Mun EC, Stoyneva V, Mantzoros CS, Goldfine AB. Peptide YY levels are elevated after gastric bypass surgery. Obesity (Silver Spring). 2006;14(2):194-198.
59. Korner J, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring). 2006;14(9):1553-1561.
60. le Roux CW, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, faci litate weight loss, and improve metabolic parameters. Ann Surg. 2006;243(1):108-114.
61. Morinigo R, et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in m orbidly obese subjects. J Clin Endocrinol Metab. 2006;91(5):1735-1740.
62. Morínigo R, Vidal J, Lacy AM, Delgado S, Casamitjana R, Gomis R. Circulating peptide YY, weight loss, and g lucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg. 2008;247(2):270-275.
63. Oliván B, et al. Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Ann Surg. 2009;249(6):948-953.
64. Bose M, et al. Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Silver Spring). 2010;18(6):1085-1091.
65. Jacobsen SH, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22(7):1084-1096.
66. Yousseif A, et al. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and acti ve GLP-1 levels in non-diabetic humans. Obes Surg. 2014;24(2):241-252.
67. le Roux CW, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246(5):780-785.
68. Yan W, et al. Effects of meal size on the release of GLP-1 and PYY after Roux-en-Y gastric bypass surgery in obese subjects with or without type 2 diabetes. Obes Surg. 2014;24(11):1969-1974.
69. Dar MS, et al. GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)? Obes Surg. 2012; 22(7):1077-1083.
70. Malik S, McGlone F, Bedrossian D, Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab. 2008;7(5):400-409.
71. Batterham RL, et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature. 2007;450(7166):106-109.
72. De Silva A, et al. The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab. 2011;14(5):700-706.
73. Manning S, Batterham RL. The role of gut hormone peptide YY in energy and glucose homeostasis: twelve years on. Annu Rev Physiol. 2014;76:585-608.
74. Dirksen C, et al. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss respon se after Rouxen-Y gastric bypass. Int J Obes (Lond). 2013;37(11):1452-1459.
75. Fenske WK, Bueter M, Miras AD, Ghatei MA, Bloom SR, le Roux CW. Exogenous peptide YY3-36 and Exendin-4 fur ther decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass. Int J Obes (Lond). 2012;36(3):379-384.
76. Abegg K, Schiesser M, Lutz TA, Bueter M. Ac ute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass. Physiol Behav. 2013;121:70-78.
77. Ye J, et al. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Integr Comp Physiol. 2014;306(5):R352-R362.
78. Mokadem M, Zechner JF, Margolskee RF, Drucker DJ, Aguirre V. Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency. Mol Metab. 2014;3(2):191-201.
79. Llewellyn-Smith IJ, Reimann F, Gribble FM, Trapp S. Preproglucagon neurons project widely to autonomic control areas in the mouse brain. Neuroscience. 2011;180:111-121.
80. Yamamoto H, et al. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest. 2002;110(1):43-52.
81. Strader AD, Vahl TP, Jandacek RJ, Woods SC, D'Alessio DA, Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab. 2005;288(2):E447-E453.
82. Chandarana K, et al. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes. 2011;60(3):810-818.
83. Suzuki K,Jayasena CN,Bloom SR Obesity and appetite control Exp Diabetes Res. 2012, 2012, 824305.
84. Cummings DE, et al. Pl asma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346(21):1623-1630.
85. Barazzoni R, et al. Gastric bypass does not normalize obesity-related changes in ghrelin profile and leads to higher acylated ghrelin fraction. Obesity (Silver Spring). 2013;21(4):718-722.
86. Falkén Y, Hellström PM, Holst JJ, Näslund E. Changes in glucose homeostasis aft er Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab. 2011;96(7):2227-2235.
87. Chronaiou A, Tsoli M, Kehagi as I, Leotsinidis M, Kalfarentzos F, Alexandrides TK. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric b ypass: a randomized clinical trial. Obes Surg. 2012;22(11):1761-1770.
88. Peterli R, et al. Metabolic and hormonal changes after laparoscopic Rouxen-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22(5):740-748.
89. Laferrére B, et al. Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes. J Clin Endocrinol Metab. 2010;95(8):4072-4076.
90. Field BC, et al. PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans. Diabetes. 2010;59(7):1635-1639.
91. Stanley S, Buettner C. FGF19: How gut talks to brain to keep your sugar down. Mol Metab. 2014;3(1):3-4.
92. Liou AP, Paziuk M, Luevano JM Jr., Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5(178):178ra41.
93. Browning KN, Fortna SR, Ha jnal A. Roux-en-Y gastric bypass reverses the effects of dietinduced obesity to inhibit the responsiveness of central vagal motoneurones. J Physiol. 2013;591(pt 9):2357-2372.
94. Ryan KK, et al. FX R is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014;509(7499):183-188.
95. Steinert RE, et al. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity (Silver Spring). 2013;21(12):E660-E668.
96. Sweeney TE, Morton JM. Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota ? A summary of the literature. Best Pract Res Clin Gastroenterol. 2014;28(4):727-740.
97. Watanabe M, et al. Bile acids i nduce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439(7075):484-489.
98. Shin AC, Berthoud HR. Food reward functions as affected by obesity and bariatric surgery. Int J Obes (Lond). 2011;35(suppl 3):S40-S44.
99. Ochner CN, et al. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg. 2011;253(3):502-507.
100. Ochner CN, et al. Relation between changes in neural responsivity and reductions in desire to eat high-calorie foods following gastric bypass surgery. Neuroscience. 2012;209:1 28-135.
101. Ochner CN, Laferrére B, Afifi L, Atalayer D, Geliebter A, Teixeira J. Neural responsivity to food cues in fasted and fed states pre and post gastric bypass surgery. Neurosci Res. 2012;7 4(2):138-143.
102. Scholtz S, et al. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut. 2014;63(6):891-902.
103. de Weijer BA, et al. Striatal dopamine receptor binding in morbidly obese women before and after gastric bypass surgery and its relationship with insulin sensitivity. Diabetologia. 2014;57(5):1078-1080.
104. Frank S,et al Altered brain activity in severely obese women may recover after Roux-en Y gastric bypass surgery Int J Obes (Lond). 2014, 38, 3, 341-348.
105. Stefater MA, Wilso n-Pérez HE, Chambers AP, Sandoval DA, Seeley RJ. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev. 2012;33(4):595-622.
106. Seyfried F, le Roux CW, Bu eter M. Lessons learned from gastric bypass operations in rats. Obes Facts. 2011;4(suppl 1):3-12.
107. Wilson-Perez HE, et al. The effect of vertical sleeve gastrectomy on food choice in rats. Int J Obes (Lond). 2013;37(2):288-295.
108. Zheng H, et al. Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol. 2009;297(5):R1273-R1282.
109. Shin AC, Zheng H, Pistell PJ, Berthoud HR. Roux-en-Y gastric bypass surgery changes food reward in rats. Int J Obes (Lond). 2011;35(5):642-651.
110. le Roux CW, et al. Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol. 2011;301(4):R1057-R1066.
111. Shin AC, Zheng H, Townsend RL, Patterson LM, Holmes GM, Berthoud HR. Longitudinal assessment of food intake, fecal energy loss, and energy expenditure after Roux-en-Y gastric bypass surgery in high-fat-fed obes e rats. Obes Surg. 2013;23(4):531-540.
112. Furnes MW, Tømmerås K, Arum CJ, Zhao CM, Chen D. Gastric bypass surgery causes body weight loss without reducing food intake in rats. Obes Surg. 2008;18(4):415-422.
113. Furnes MW, et al. Feeding behavior in rats subjected to gastrectomy or gastric bypass surgery. Eur Surg Res. 2008;40(3):279-288.
114. Bueter M, et al. Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg. 2010;20(5):616-622.
115. Hao Z, Townsend RL, Mumphrey MB, Patterson LM, Ye J, Berthoud HR. Vagal innervation of intestine contributes to weight loss After Roux-en-Y gastric bypass surgery in rats. Obes Surg. 2014;24(12):2145-2151.
116. Shi n AC, Zheng H, Berthoud HR. Vagal innervation of the hepatic portal vein and liver is not necessary for Roux-en-Y gastric bypass surgery induced hypophagia, weight loss, and hypermetabolism. Ann Surg. 2012;255(2):294-301 .
117. Perathoner A, et al. Vagal nerve dissection during pouch formation in laparoscopic Roux-Y-gastric bypass for technical simplification: does it matter? Obes Surg. 2009;19(4):412-417.
118. Plamboeck A, et al. The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty. Am J Physiol Gastrointest Liver Physiol. 2013;304(12):G1117-G1127.
119. Girardet C, Butler AA. Neural melanocortin receptors in obesity and related metabolic disorders. Biochim Biophys Acta. 2014;1842(3):482-494.
120. Hatoum IJ, et al. Melanocorti n-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab. 2012;97(6):E1023-E1031.
121. Moore BS, et al. Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants. PLoS One. 2014;9(4):e93629.
122. Mirshahi UL, Still CD, Masker KK, Gerhard GS, Carey DJ, Mirshahi T. The MC4R(I251L) allele is associated with b etter metabolic status and more weight loss after gastric bypass surgery. J Clin Endocrinol Metab. 2011;96(12):E2088-E2096.
123. Mumphrey MB, et al. Reversible hyperphagia and obesity in rats with gastric bypass by central MC3/4R blockade. Obesity (Silver Spring). 2014;22(8):1847-1853.
124. Zechner JF, et al. Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans. Gastroenterology. 2013;144(3):580-590.
125. Panaro BL, et al. The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo. Cell Metab. 2014;20(6):1018-1029.
126. Xiang Z, et al. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry. 2006;45(23):7277-7288.
127. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels aft er Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247(3):401-407.
128. Kashyap SR, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013;36(8):2175-2182.